Page last updated: 2024-10-28

hypericin and Leishmaniasis, Visceral

hypericin has been researched along with Leishmaniasis, Visceral in 1 studies

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, S1
Kumari, E1
Bhardwaj, R1
Kumar, R1
Dubey, VK1

Other Studies

1 other study available for hypericin and Leishmaniasis, Visceral

ArticleYear
Molecular events leading to death of Leishmania donovani under spermidine starvation after hypericin treatment.
    Chemical biology & drug design, 2017, Volume: 90, Issue:5

    Topics: Adenosine Triphosphate; Anthracenes; Gene Expression Regulation; Humans; Leishmania donovani; Leishm

2017